(1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid - Names and Identifiers
Name | (1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid
|
Synonyms | Swertiaside (1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid (1S,4aS,6R,7R,7aS)-6-(3-hydroxybenzoyl)oxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid
|
CAS | 96087-14-8
|
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid - Physico-chemical Properties
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid - Introduction
(1S)-1α-(β-D-glucopyranosyloxy)-1,4a α,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid is a compound, has the following properties and uses:
Nature:
-chemical formula: C29H38O12
-Molecular weight: 578.6g/mol
-Appearance: colorless crystalline powder
-Melting Point: 229-233 ℃
-Solubility: Slightly soluble in water, soluble in some organic solvents
Use:
- (1S)-1α-(β-D-glucopyranosyloxy)-1,4a α,5,6,7,7aα-hexahydro-6β-(3-hydroxybenzoyloxy)-7α-methylcyclopenta[c]pyran-4-carboxylic acid has pharmacological activities such as antibacterial, anti-inflammatory and antioxidant activities, and therefore may be used in the field of medicine.
Method:
-The specific preparation method may be a trade secret, so detailed steps cannot be provided. Generally speaking, the preparation of a certain compound may require a series of chemical reaction steps, including the selection of synthetic raw materials, the optimization of reaction conditions, etc.
Safety Information:
-The safety of chemicals is closely related to the methods and conditions of use. In the case of this compound, safety information and relevant toxicological and physiological data cannot be provided due to lack of specific information. When using compounds, it is recommended to follow the corresponding safety procedures, and evaluate their risks and applicability in food, cosmetics, drugs, etc. according to the actual situation.
Last Update:2024-04-09 15:18:04